{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:23:57Z","timestamp":1783632237125,"version":"3.55.0"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T00:00:00Z","timestamp":1602892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Hypertension"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ijchy.2020.100058","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T04:09:09Z","timestamp":1603166949000},"page":"100058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Sodium-Glucose Cotransporter (SGLT2) inhibitors: A new Era in renovascular protection"],"prefix":"10.1016","volume":"7","author":[{"given":"Adel E.","family":"Berbari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijchy.2020.100058_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/DMSO.S233538","article-title":"GPFadini, Extraglycemic effects of SGLT2 inhibitors: a review of the evidence","volume":"13","author":"Bonora","year":"2020","journal-title":"Diabetes Metab. Syndrome Obes."},{"key":"10.1016\/j.ijchy.2020.100058_bib2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4239\/wjd.v10.i5.269","article-title":"Evolving spectrum of diabetic nephropathy","volume":"10","author":"Kopel","year":"2019","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.ijchy.2020.100058_bib3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/hr.2016.193","article-title":"Cardioprotective effects of SGLT2 inhibitors are possibly associated with normalization of the circadian rhythm of blood pressure","volume":"40","author":"Rahman","year":"2017","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ijchy.2020.100058_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/qjmed\/93.7.441","article-title":"Increased augmentation index and systolic stress in type 1 diabetes mellitus","volume":"93","author":"Wilkinson","year":"2000","journal-title":"QJM"},{"key":"10.1016\/j.ijchy.2020.100058_bib5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s13300-019-00747-3","article-title":"Renal outcomes in type 2 diabetes: a review of cardiovascular and renal outcome trials","volume":"11","author":"Williams","year":"2020","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.ijchy.2020.100058_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3171","article-title":"SGLT2 inhibition to address the unmet needs in diabetic nephropathy","volume":"35","author":"Barutta","year":"2019","journal-title":"Diabetes Metab. Res. Rev."}],"container-title":["International Journal of Cardiology Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590086220300355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590086220300355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:30:43Z","timestamp":1762911043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590086220300355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":6,"alternative-id":["S2590086220300355"],"URL":"https:\/\/doi.org\/10.1016\/j.ijchy.2020.100058","relation":{},"ISSN":["2590-0862"],"issn-type":[{"value":"2590-0862","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium-Glucose Cotransporter (SGLT2) inhibitors: A new Era in renovascular protection","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijchy.2020.100058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100058"}}